| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12:23 | China Is Said to Ease Loan Extension Rules for White List Property Projects | ||
| 12:23 | China's Yangtze River Delta Region Updates Leniency Rules to Boost Business Environment | ||
| 12:23 | China Used Car Transactions Top 20 Million Units for First Time in 2025 | ||
| 11:23 | China's Jereh Gains by Limit After Landing Second Generator Order From US AI Giant | ||
| 11:23 | Fulin Precision Gains After CATL Invests USD455 Million in Chinese Battery Materials Supplier | ||
| 10:23 | Shanghai Taps Finance to Boost Consumption in 28-Point Action Plan | ||
| 10:23 | Viral Chinese Solo Dwellers App 'Are You Dead' to Go Global Under New Name | ||
| 08:22 | China's Ronbay Bags USD17.2 Billion Lithium Battery Materials Order From CATL | ||
| 08:22 | China's Foreign Trade Climbs 3.8% to New Record in 2025 | ||
| 07:22 | Currency Race: The New Leader | ||
| 07:22 | China's Deppon Surges by Limit After JD.Com-Backed Logistics Giant Says It'll Voluntarily Delist | ||
| 07:22 | Nissan's China Sales Drop for Seventh Straight Year in 2025 | ||
| 07:22 | China's Luxshare Takes Wingtech to Court Over Indian Assets Dispute | ||
| 07:22 | China's Employee Turnover Rate Falls For Third Year in a Row in 2025 | ||
| 07:22 | China to Speed Economic Rebalancing in 2026, UBS Senior Economist Says | ||
| 07:22 | Chinese BCI Startup NeuroXess Breaks Ground on 'Super Plant,' Aims to Start Mass Production in Second Half | ||
| Di | UBS Sees 10% Profit Growth for MSCI China Index in 2026, Flags AI as Core Theme | ||
| Di | China Village Bank M&A Deals Surge 10-Fold From a Year Ago | ||
| Di | China Sets Five-Year Goal to Ramp Up Solid Waste Utilization | ||
| Di | Wus Printed Circuit Rises After Unveiling USD300 Million High-End PCB Investment | ||
| Di | China's Jinlongyu Soars on Plan to Build USD170 Million Solid-State Battery Plant | ||
| Di | China's Forehope Electronic to Invest USD300 Million to Build IC Packaging, Testing Plant in Malaysia | ||
| Di | WuXi AppTec Jumps After Chinese Drugmaker Raises 2025 Earnings Forecast Again | ||
| Di | Shanghai to Achieve Clinical Application of Invasive BCI by 2030 | ||
| Di | China's RemeGen Jumps by Limit After Granting AbbVie Novel Cancer Drug Rights in Up to USD5.6 Billion Deal |